HomeREGULATORY
REGULATORY

MHLW Official Expounds on “Authorized Biosimilar” Pricing, 50% Generic Rule Applies for “Biosame” Products
(Jul.11.2018)

Biosimilar Forum in Tokyo
If a follow-on biologic is manufactured under the exact same conditions as those for its originator, this “biosame” product will be handled as a “generic” under the current pricing rules in Japan, receiving an NHI price 50% of the originator’s, instead of the usual 70% for “biosimilars,” a senior health ministry official says ...
(LOG IN FOR FULL STORY)

News Calendar